1. Alternative mechanisms of action of anti-oestrogens.
- Author
-
Colletta AA, Benson JR, and Baum M
- Subjects
- 3',5'-Cyclic-AMP Phosphodiesterases antagonists & inhibitors, Breast Neoplasms pathology, Cell Division drug effects, Cyclic Nucleotide Phosphodiesterases, Type 1, Estradiol physiology, Estrogen Antagonists pharmacology, Female, Humans, Insulin-Like Growth Factor I physiology, Protein Kinase C antagonists & inhibitors, Receptors, Estrogen drug effects, Tamoxifen therapeutic use, Transforming Growth Factor beta physiology, Breast Neoplasms drug therapy, Estrogen Antagonists therapeutic use
- Abstract
The molecular mechanism of action of anti-oestrogens such as tamoxifen appears to be a complex mixture of antagonism of the mitogenic action of oestradiol at the level of the oestrogen receptor, plus a range of other activities from enzyme inhibition to growth factor modulation. This article will concentrate on two specific areas: 1) the inhibition of protein kinase C and calmodulin-dependent cAMP phosphodiesterase; and 2) the regulation by tamoxifen of peptide regulators of breast cancer epithelial cell growth such as insulin-like growth factor I (IGF I) and transforming growth factor beta (TGF-beta). The elucidation of these mechanisms is potentially important in the treatment and chemoprevention of breast cancer-the quantitative contribution of each individual mechanism of the overall antineoplastic action of anti-oestrogens is central to developing new and possibly more effective anti-oestrogens and optimizing strategies for their use.
- Published
- 1994
- Full Text
- View/download PDF